Epizyme, Inc. (EPZM) Social Stream
EPIZYME INC (EPZM) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering EPZM.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-10 | 5 | $15 | $5 | $10 | $1.52 | 557.89% |
2022-01-10 | 4 | $15 | $3 | $10.5 | $1.52 | 590.79% |
2022-01-28 | 4 | $15 | $2 | $10.25 | $1.52 | 574.34% |
2022-03-01 | 4 | $15 | $2 | $9.25 | $1.52 | 508.55% |
2022-05-11 | 4 | $10 | $2 | $7.25 | $1.52 | 376.97% |
2022-05-12 | 4 | $10 | $0.6 | $6.4 | $1.52 | 321.05% |
2022-06-03 | 4 | $8 | $0.6 | $5.4 | $1.52 | 255.26% |
2022-06-28 | 4 | $6 | $0.6 | $2.387 | $1.52 | 57.04% |
The Trend in the Analyst Price Target
EPZM's average price target has moved down $4.86 over the prior 48 days.
Over the past 33 weeks, EPZM's average upside potential has been 559.6%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-10 | 4 | 15 | 5.0 | 11.00 | 4.830 | 127.74% |
2021-11-10 | 5 | 15 | 5.0 | 10.00 | 4.830 | 107.04% |
2021-12-22 | 4 | 15 | 3.0 | 10.50 | 3.020 | 247.68% |
2022-01-21 | 4 | 15 | 2.0 | 10.25 | 2.070 | 395.17% |
2022-05-11 | 4 | 10 | 0.6 | 6.40 | 0.468 | 1267.52% |
EPZM Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
2.5 | 1 | 0 | 3 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 26 weeks, EPZM's average broker recommendation rating worsened by 0.5.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, EPIZYME INC's variance in analysts' estimates is lower than -835.33% of them.
- EPIZYME INC's average analyst price target is higher than 68.05% of all US stocks.
- In terms of how EPIZYME INC fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 914.13% of that group.
- EPIZYME INC's number of analysts covering the stock is higher than 165.59% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, ENTA, EBS, and DVAX are the three stocks most similar to EPIZYME INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is EPZM a Buy, Hold or Sell? See the POWR Ratings now!